1. Generic & Brand Names
Generic: Dicyclomine HCl
Brands: Bentyl® (US/Canada), Antispas® (EU), Dibent® (India)
Formulations:
Tablets (10mg, 20mg)
Capsules (10mg, 20mg)
Oral solution (10mg/5mL)
Injectable (10mg/mL) - IM only
2. Drug Class & Mechanism
Class: Anticholinergic/Antispasmodic
Mechanism:
Blocks muscarinic acetylcholine receptors in GI smooth muscle → ↓ spasms
Reduces gastric motility → relieves cramping/pain
Minimal CNS effects vs. other anticholinergics
3. FDA-Approved Uses
| Condition | Key Applications |
|---|---|
| Irritable Bowel Syndrome (IBS) | Abdominal pain/cramping relief |
| Functional GI Disorders | Colitis, diverticulitis spasms |
| Off-label: | Renal/biliary colic |
4. Dosing Regimens
| Group | Acute Dose | Maintenance | Max Daily |
|---|---|---|---|
| Adults | 20 mg QID (before meals) | 10-20 mg TID-QID | 80 mg |
| Elderly | 10 mg BID-TID | 5-10 mg BID | 30 mg |
| Administration Rules: |
Take 15-30 min BEFORE meals
Start low (10 mg) → titrate to avoid side effects
Avoid >2 weeks without reevaluation
5. Black Box Warnings & Contraindications
🚫 Absolute Contraindications:
Infants <6 months (↑ seizure risk)
Glaucoma (angle-closure)
Myasthenia gravis
Severe ulcerative colitis
GI obstruction
High-Risk Groups:
Elderly (>65 yrs): ↑ confusion/urinary retention
Autonomic neuropathy (e.g., diabetes)
Benign prostatic hyperplasia (BPH)
6. Side Effects
| Common (≥20%) | Serious (<1%) |
|---|---|
| Dry mouth | Tachycardia |
| Dizziness | Urinary retention |
| Blurred vision | Paralytic ileus |
| Constipation | Heat stroke (↓ sweating) |
| Nausea | Acute glaucoma |
7. Critical Drug Interactions
| Medication | Risk | Action |
|---|---|---|
| Other Anticholinergics | Scopolamine, TCAs | ↑ Toxicity → avoid combo |
| Opioids | ↑ Constipation/ileus risk | Monitor bowel function |
| Alcohol | ↑ Sedation | Avoid |
| CNS Depressants | Benzodiazepines, antipsychotics | ↓ Dose both agents |
8. Special Populations
| Group | Recommendation |
|---|---|
| Pregnancy (Cat B) | Use only if benefit > risk |
| Lactation | Avoid (infant anticholinergic effects) |
| Children | Contraindicated <6 months; limited data >6 months |
| Renal/Hepatic | Max 10 mg BID |
9. Clinical Use for IBS
Target Symptoms: Cramping, urgency, abdominal pain
Avoid for: Predominant constipation (IBS-C)
Combine with:
Fiber supplements (psyllium)
Low-FODMAP diet
Probiotics (e.g., Bifidobacterium infantis)
10. Administration Alerts
IM Injection Only:
Never give IV (causes thrombosis)
Rotate injection sites
Oral Solution:
Measure with calibrated syringe (not spoon)
Shake well before use
Clinical Practice Tips
✅ Effective When:
Spasms triggered by meals/stress
IBS with diarrhea (IBS-D) predominance
Acute cramping episodes
❌ Ineffective For:Inflammatory causes (e.g., Crohn's disease)
Chronic pain without spasms
Bloating/gas relief
⚠️ Safety Monitoring:
Assess for urinary retention (post-void residual volume if suspected)
Check intraocular pressure if glaucoma risk
Discontinue if confusion/hallucinations occur
Dicyclomine vs. Alternative Antispasmodics
| Parameter | Dicyclomine | Hyoscyamine | Mebeverine |
|---|---|---|---|
| CNS Penetration | Low | Moderate | None |
| Onset | 1-2 hours | 30 min | 1 hour |
| IBS Evidence | Moderate | Limited | Strong (EU/Asia) |
| Safety in Elderly | High risk | High risk | Low risk |
Patient Counseling
"Take before meals to prevent spasms."
"Discontinue if:
Eye pain/redness (glaucoma)
Difficulty urinating
Severe constipation"
"Avoid heat exposure – reduces sweating → heat stroke risk."
"Limit driving until dizziness assessed."
💡 Pro Tip: For IBS-D, combine with loperamide (imodium) for diarrhea control after spasm relief.
Prescribing Status: Rx-only; avoid long-term use (>3 months).
Cost: Generic tablets cost <$0.10/dose.
Sources: ACG IBS Guidelines (2021), FDA Safety Review (2020).
Comments
Post a Comment